Brokerages Set 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Target Price at $35.70
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) have earned an average rating of “Moderate Buy” from the nine research firms that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12-month […]
More Stories
Trump Says US Has ‘Virtually Unlimited’ Weapons Stockpiles
By Guy Birchall President Donald Trump said on March 3 that the United States has a “virtually unlimited supply” of...
Trump Criticizes Starmer, Says Special Relationship in Peril
By Owen Evans President Donald Trump has criticised British Prime Minister Keir Starmer and warned that the historic U.S.–UK Special...
Alone Season 11 is Live on Netflix: Know About Release Date, Participants, and Winner
Why is Alone season 11 getting a sudden hype after its original release date on 13 June 2024? There are...
Who is George Russell? Number 63 Driver of Formula One Racing
If you follow car racing closely, you must know who is George Russell. One who started as a kart racer...
What is Project Management? 5 Best Project Management Tools that You Can Try
Are you also looking for the best project management tool that will help you automate repetitive tasks and save time?...
US Sent B-1 Bombers ‘Deep Inside Iran,’ CENTCOM Says
By Jack Phillips The U.S. military sent B-1 bombers “deep inside Iran” to target the Iranian regime’s ballistic missile systems...